MoneyWorks4Me

The sales is pegged at Rs. 179.43 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 246.36 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -54.96 millions as compared to Net Loss of Rs. -151.12 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -1.78% as compared to -110.71% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 179.43 246.36 -27.17 179.43 246.36 -27.17 1036.04 1367.97 -24.26
Other Income 3.60 0.03 11900.00 3.60 0.03 11900.00 41.85 95.72 -56.28
PBIDT -1.78 -110.71 -98.39 -1.78 -110.71 -98.39 -103.34 -240.68 -57.06
Interest 5.22 2.51 107.97 5.22 2.51 107.97 25.31 19.04 32.93
PBDT -7.00 -113.22 -93.82 -7.00 -113.22 -93.82 -128.65 -259.72 -50.47
Depreciation 47.96 37.90 26.54 47.96 37.90 26.54 186.31 184.10 1.20
PBT -54.96 -151.12 -63.63 -54.96 -151.12 -63.63 -314.96 -443.82 -29.03
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -54.96 -151.12 -63.63 -54.96 -151.12 -63.63 -314.96 -443.82 -29.03
Equity 165.83 165.83 0.00 165.83 165.83 0.00 165.83 165.83 0.00
PBIDTM(%) -0.99 -44.94 -97.79 -0.99 -44.94 -97.79 -9.97 -17.59 -43.31

Vivimed Labs Share Price

4.99 -0.08 (-1.58%)
13-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.85
Dr. Reddys Labs. 1206.00
Cipla 1461.00
Lupin 2261.00
Zydus Lifesciences 1173.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: